Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Infographics

While many partnerships fail to deliver real economic value, here's how one CEO broke through.

CEO, UW Health
Partner, Health and Life Sciences, Oliver Wyman

Let the Survival of the Fittest Begin

How healthcare leaders can better understand what makes their businesses tick amid factors they can’t control.  

Principal, Health and Life Sciences, Oliver Wyman
Partner, Financial Services, Oliver Wyman

Featured in The Dallas Morning News

Executives who care about diversity should examine the track in their companies to senior management.

Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

A Singapore Case Study

Singapore is the world's second-fastest aging country. Opportunities for digital, consumer-centric strategies aim to make aging-in-place the norm.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

New Predictions on COVID-19 Vaccines and Herd Immunity

How COVID-19 case counts and vaccines may get us back to normalcy by June.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Hard-hitting yet human-centered consumer communications will ensure more patients don't delay necessary medical care.

Chief Marketing and Communications Officer, Memorial Sloan Kettering
Senior Partner, Lippincott
Partner, Health and Life Sciences, Oliver Wyman

Forty-four percent of Americans say they have less trust in federal government officials as a result of the COVID-19 crisis.

Partner, Oliver Wyman Public Sector, and Visiting Fellow, London School of Economics Centre for Risk and Regulation
Partner, Oliver Wyman

Summary of CY2022 Advance Notice Summary Part II

CMS proposes Stars rating changes, revises MA plan definitions, calls for new COVID-19 vaccination measures, and more.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.

Principal, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe